Alzey Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 16-11-2024
- Paid Up Capital ₹ 3.50 M
as on 16-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
as on 16-11-2024
- Revenue 13.31%
(FY 2023)
- Profit 22.40%
(FY 2023)
- Ebitda 97337.12%
(FY 2023)
- Net Worth 42.60%
(FY 2023)
- Total Assets 38.66%
(FY 2023)
About Alzey Pharmaceuticals
The Corporate was formerly known as Alzey Pharmaceutical Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹1.00 Cr.
Ajay Soni, Sumeet Chaudhry, Sanjeet Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U51397HR2020PTC089594
- Company No.
089594
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Alzey Pharmaceuticals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Preeti Chaudhry  | Director | 09-Apr-2022 | Current |
| Ajay Soni | Director | 09-Apr-2022 | Current |
| Sumeet Chaudhry | Additional Director | 18-Jan-2021 | Current |
| Sanjeet Kumar | Additional Director | 03-Jul-2021 | Current |
| Puneet Chaudhry | Director | 09-Apr-2022 | Current |
Financial Performance of Alzey Pharmaceuticals.
Alzey Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.31% increase. The company also saw a substantial improvement in profitability, with a 22.4% increase in profit. The company's net worth Soared by an impressive increase of 42.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alzey Pharmaceuticals?
Unlock access to Alzey Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Jainav Nuorganiks Private LimitedActive 2 years 6 monthsPuneet Chaudhry and Preeti Chaudhry are mutual person
- Rozzheal Private LimitedActive 2 years 6 months
Puneet Chaudhry and Preeti Chaudhry are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Feb 2021 | ₹1.00 Cr | Open |
How Many Employees Work at Alzey Pharmaceuticals?
Alzey Pharmaceuticals has a workforce of 0 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alzey Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alzey Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
